Table 1 Main clinical features of the Latin America leishmaniasis cases and results of sequencing of the cytochrome b fragment

Visited country

 Bolivia

–

1

–

–

 Costa Rica

–

–

–

1

 French Guiana

5

–

–

–

 Mexico

–

–

2

–

 Peru

2

1

–

–

Length of stay

  < 30 days

6

1

1

1

 30–90 days

–

1

–

–

  > 90 days

1

–

1

–

Occurrence of skin lesions

  < 30 days after return

5

2

1

–

 30–100 days after return

2

–

1

1

Delay for seeking medical assistance

  ≤ 90 days

3

2

1

  > 90 days

4

2

Exudative lesions

4

2

0

1

Treatment^a

 Pentamidine

4

–

–

1

 Intralesional meglumine antimoniate

–

1^b

1

–

 Liposomal amphotericin B

2

1^b

–

–

 Itraconazole

1^c

–

–

–

Cytochrome b sequencing

 Reference sequence GeneBank access number

AB095969.1

LC472861.1

AB095963.1

MK570510

 SNP

Absence

Absence

C53T (Met- > Thr) and A584G (Gln- > Gln)

absence